Category: In the News

COVID-19 Vaccine and Fertility: What You Need To Know

Graphic of COVID-19 Vaccine and Fertility, What You Need to KnowLately, we hear many questions from patients about the COVID-19 vaccine and fertility and impact on pregnancy.

Vios Fertility Institute follows the guidelines from both the American Society for Reproductive Medicine (ASRM) and The American College of Obstetricians and Gynecologists (ACOG) in recommending that pregnant women, and women seeking to become pregnant, get the vaccine as it becomes available. These guidelines are constantly adjusted as new data is available and our team will continue to stay on top of the changes.

What else do you need to know about the COVID-19 vaccine and its impact on fertility?

  • Both the Pfizer and Moderna vaccines are messenger ribonucleic acid (mRNA)-based and therefore do not contain the live virus. This means that the vaccine elicits an immune response so if the recipient were to get COVID-19 she would have some immunity over it.
  • The vaccine does NOT appear to interfere with fertility in men or women.

Dr. MacKenzie Purdy and Dr. Roohi Jeelani answered many questions on this topic during our Instagram Live this week. Click below to watch!

 

View this post on Instagram

 

A post shared by Vios Fertility (@viosfertility)

ASPIRE Study: COVID19 and Pregnancy

Vios Fertility Institute is proud to partner with the University of California-San Francisco to make patients aware of the ASPIRE study regarding COVID19 and pregnancy. ASPIRE stands for Assessing Safety of Pregnancy In the Coronavirus Pandemic.

ASPIRE study on COVID19 and pregnancy

ASPIRE is a nationwide prospective cohort study of pregnant women and their offspring during the COVID-19 pandemic. All Society for Assisted Reproductive Technology (SART) member clinics have been invited to share this study information with their pregnant patients, directing patients to register to participate at this website.

From ASPIRE, “The goal of this study is to help understand the spread of COVID-19 infection among pregnant women and how infection might affect the health and wellbeing of pregnant mothers and their babies, particularly when the infection occurs in early pregnancy or without any symptoms. The goal is for this knowledge to inform and empower pregnant women and their healthcare providers to provide the best possible care for their pregnancies and future babies. Also, women and couples planning pregnancies will gain important information to help make decisions for their families.”

ASPIRE is focused on the first trimester, a critical and vulnerable period when all of a baby’s organ systems form and the placenta – the crucial connection between mom and baby – develops.

Currently, there are no data about the effects of COVID19 infections in the first trimester. The ASPIRE study will provide critical information to:

(1) Guide the care of pregnant women
(2) Protect the safety of their babies and families
(3) Help those considering pregnancy in the future understand what it means to be pregnant in this new era

Becoming pregnant at any time is a personal choice and with the added uncertainty of a global pandemic, we realize this decision did not come lightly. We celebrate your pregnancy!

We’re also careful to counsel our patients at every step of their care journey about COVID19 and pregnancy considerations and safety guidelines so that you can feel informed and an active and empowered partner in your care.

Who can join the ASPIRE Study?
Anyone who is over the age of 18 and is between 4 – 10 weeks pregnant. Eligible participants will be compensated financially.

  1. You’ll be asked to:
    1. Submit frequent, quick (<1 minute each) symptom tracking reports using your mobile phone and/or computer.
  2. 2. Collect finger-stick blood samples from home at several points throughout your pregnancy. (A helpful how to video is here.)
  3. 3. Give permission to review medical records related to your pregnancy, delivery and baby’s development.
  4. 4. Complete questionnaires online about your health during your pregnancy and after delivery of your baby.

How to get started:

Visit https://aspire.ucsf.edu/ to learn more and register on their website here.

Do you have additional questions about COVID-19 and fertility treatment at Vios? Click here for our latest update.

Miscarriage Treatment Options: Dr. MacKenzie Purdy Answers Your Questions

Miscarriage is a heartbreaking reality for many as they try to conceive and, sometimes, a woman can experience multiple miscarriages in a row.

Recurrent Pregnancy Loss (RPL) is defined by the American Society for Reproductive Medicine (ASRM) as two or more consecutive pregnancy losses. We know this is a heartbreaking loss and we are committed to helping our patients find answers and treatment options to help.

The first step is a series of diagnostic tests to understand what may be causing the miscarriages. There are some common causes of RPL including genetic, hormone imbalance, uterine abnormality, and undiagnosed medical conditions. Some reasons remain unknown despite the myriad of available testing options.

Dr. MacKenzie Purdy, a Vios physician in our St. Louis region, spoke with FOX2 in St. Louis about miscarriage and recurrent pregnancy loss. Watch for more information about diagnosis and testing as well as various treatment options for RPL.

After the interview, Dr. Purdy answered patient questions on the topic during a Facebook Live.

The future of egg and embryo storage: The TMRW Platform

Vios Fertility Institute is proud to partner with companies like TMRW to raise the standard of care for fertility patients.

This morning, Dr. Angie Beltsos, Vios CEO and Chief Medical Officer, along with TMRW Founder and Co-CEO Joshua Abram, spoke to Maria Bartiromo on Fox Business Network to share the unprecedented safety and innovation TMRW is bringing to the fertility industry.

Watch Joshua and Angie explain just how monumental this shift is on today’s Mornings With Maria here:

Dr. Angie Beltsos

Dr. Angie Beltsos on Fox Business talking about innovations in embryo storage

Fertility Preservation and COVID-19

During the COVID-19 pandemic female fertility preservation (aka “egg freezing”) has increased. This recent article highlights the trend in the United States.

At Vios, we’ve seen a similar increase in fertility preservation treatment.

Today, Dr. Roohi Jeelani of Vios Fertility Institute in Chicago shared her experience and expertise on the topic with Chicago’s ABC7.

Ovarian Reserve and Your Fertility

As fertility specialists, we’re asked a lot about ovarian health and ovarian reserve – specifically egg quantity and quality.

A woman is born with all the eggs she’ll ever have. At birth, a baby girl typically has about 1 million eggs and by puberty this number has declined to 500,000. Each month, a handful of eggs are eligible to become mature but only one will be ovulated. (For a detailed description of this process, click here.)

Ovary with ovulation

Age is one of the most important factors in a woman’s fertility potential. Yet, there is no “magic” age and recent studies show that genetics and the environment also play an important role in egg and reproductive health.

Anti-mullerian hormone (AMH) and antral follicle count (AFC) are the most useful predictors of the number of eggs a woman has remaining. Bloodwork and ultrasound tests – along with a conversation with a reproductive endocrinologist and infertility specialist – can help you understand your current ovarian reserve.

Dr. Violet Klenov recently shared information about ovarian health, how to determine the number of eggs you may have, and how to improve egg quality with St. Louis’s Fox2. Watch the full story below.

Additionally, Dr. Klenov answered patient questions on this topic. Click below to watch the Q&A.

To schedule a consultation to take control of your fertility health, contact us today.

Vios Announce Louise Brown as Ambassador

Vios Fertility Institute Announces Louise Brown as A Brand Ambassador

CHICAGO, IL (August 12, 2019) —Known to many as the “world’s first test tube baby,” the UK’s Louise Brown is still making headlines some forty-one years later. But this time, it’s for her new role as a brand ambassador Vios Fertility Institute, one of the fastest growing fertility clinics in the U.S. (more…)

Reflecting on the Field of Reproductive Medicine

This wonderful, challenging, rewarding and at times heart breaking field of reproductive medicine is ever changing and expanding with new technologies, treatments, and techniques. All with the goal of welcoming new life into this world. To continue to innovate and push our field forward, it is important to look back at where we started and how far we have come.

(more…)

Vios Fertility St. Louis Welcomes Two New Physicians

Vios Fertility Institute St. Louis Welcomes Two New Physicians to its Team of Fertility Experts

St. Louis, MO (August 1, 2019) — Doctors Amber Cooper, MD, MSCI, FACOG (medical and IVF practice director), and Julie Rhee, MD, FACOG of Vios Fertility Institute St. Louis are pleased to announce the addition of Violet Klenov, MD, FACOG, and MacKenzie Purdy, MD, FACOG to the team. Both women are fellowship-trained, board eligible reproductive endocrinologists and infertility specialists. (more…)

In the News: A third of US adults say they or someone they know has used fertility treatments

A third of US adults say they or someone they know has used fertility treatments: Study

Article by: Lindsey Jacobson, ABC News, July 18, 2018

“Forty years after the first ever “test tube baby” Louise Joy Brown was born, 33 percent of American adults report using fertility treatment or knowing someone who used fertility treatment to have a baby, according to a new study.” Read the article here.

fertility treatments

From Left: Louise Brown, world’s first IVF baby, Dr. Amber Cooper, and Dr. Angeline Beltsos.